{"id":"https://openalex.org/W4403528215","doi":"https://doi.org/10.1016/j.xphs.2024.10.014","title":"Scale-up and clinical bioavailability assessment of a 45% drug loaded amorphous nanoparticle formulation of a BCS IV compound for oral delivery","display_name":"Scale-up and clinical bioavailability assessment of a 45% drug loaded amorphous nanoparticle formulation of a BCS IV compound for oral delivery","publication_year":2024,"publication_date":"2024-10-18","ids":{"openalex":"https://openalex.org/W4403528215","doi":"https://doi.org/10.1016/j.xphs.2024.10.014","pmid":"https://pubmed.ncbi.nlm.nih.gov/39427713"},"language":"en","primary_location":{"id":"doi:10.1016/j.xphs.2024.10.014","doi":"https://doi.org/10.1016/j.xphs.2024.10.014","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.xphs.2024.10.014","pdf_url":null,"source":{"id":"https://openalex.org/S130661733","display_name":"Journal of Pharmaceutical Sciences","issn_l":"0022-3549","issn":["0022-3549","1520-6017"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Pharmaceutical Sciences","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5101635279","display_name":"Mengqi Yu","orcid":"https://orcid.org/0009-0002-5923-5982","observed_orcids":["https://orcid.org/0009-0002-5923-5982"]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mengqi Yu","raw_affiliation_strings":["Small molecule CMC development, Drug Product Development, AbbVie Inc., North Chicago, IL 60064, United States"],"raw_orcid":"https://orcid.org/0009-0002-5923-5982","affiliations":[{"raw_affiliation_string":"Small molecule CMC development, Drug Product Development, AbbVie Inc., North Chicago, IL 60064, United States","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020255473","display_name":"Deliang Zhou","orcid":"https://orcid.org/0000-0003-0689-890X","observed_orcids":["https://orcid.org/0000-0003-0689-890X"]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Deliang Zhou","raw_affiliation_strings":["Small molecule CMC development, Drug Product Development, AbbVie Inc., North Chicago, IL 60064, United States"],"raw_orcid":"https://orcid.org/0000-0003-0689-890X","affiliations":[{"raw_affiliation_string":"Small molecule CMC development, Drug Product Development, AbbVie Inc., North Chicago, IL 60064, United States","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028695008","display_name":"Hardeep S. Oberoi","orcid":"https://orcid.org/0000-0003-4800-496X","observed_orcids":["https://orcid.org/0000-0003-4800-496X"]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hardeep S. Oberoi","raw_affiliation_strings":["Small molecule CMC development, Drug Product Development, AbbVie Inc., North Chicago, IL 60064, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Small molecule CMC development, Drug Product Development, AbbVie Inc., North Chicago, IL 60064, United States","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053884536","display_name":"Ahmed Hamed Salem","orcid":"https://orcid.org/0000-0002-9261-1583","observed_orcids":["https://orcid.org/0000-0002-9261-1583"]},"institutions":[{"id":"https://openalex.org/I107720978","display_name":"Ain Shams University","ror":"https://ror.org/00cb9w016","country_code":"EG","type":"education","lineage":["https://openalex.org/I107720978"]},{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["EG","US"],"is_corresponding":false,"raw_author_name":"Ahmed Hamed Salem","raw_affiliation_strings":["Clinical Pharmacy, Ain Shams University, Cairo, Egypt; Clinical Pharmacology, AbbVie Inc., North Chicago, IL, USA"],"raw_orcid":"https://orcid.org/0000-0002-9261-1583","affiliations":[{"raw_affiliation_string":"Clinical Pharmacy, Ain Shams University, Cairo, Egypt; Clinical Pharmacology, AbbVie Inc., North Chicago, IL, USA","institution_ids":["https://openalex.org/I107720978","https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064340798","display_name":"Laura A. McKee","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Laura A. McKee","raw_affiliation_strings":["Process Research and development, Technical Operations, AbbVie Inc., North Chicago, IL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Process Research and development, Technical Operations, AbbVie Inc., North Chicago, IL, USA","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5114318011","display_name":"Jason R Arnholt","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jason R. Arnholt","raw_affiliation_strings":["Small molecule CMC development, Analytical Research and Development, AbbVie Inc., North Chicago, IL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Small molecule CMC development, Analytical Research and Development, AbbVie Inc., North Chicago, IL, USA","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065235454","display_name":"Hitesh S. Purohit","orcid":"https://orcid.org/0000-0002-4789-3032","observed_orcids":["https://orcid.org/0000-0002-4789-3032"]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Hitesh S. Purohit","raw_affiliation_strings":["Small molecule CMC development, Drug Product Development, AbbVie Inc., North Chicago, IL 60064, United States. Electronic address: hitesh.purohit@abbvie.com"],"raw_orcid":"https://orcid.org/0000-0002-4789-3032","affiliations":[{"raw_affiliation_string":"Small molecule CMC development, Drug Product Development, AbbVie Inc., North Chicago, IL 60064, United States. Electronic address: hitesh.purohit@abbvie.com","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5017289651","display_name":"Devalina Law","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Devalina Law","raw_affiliation_strings":["Small molecule CMC development, Drug Product Development, AbbVie Inc., North Chicago, IL 60064, United States. Electronic address: devalina.law@abbvie.com"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Small molecule CMC development, Drug Product Development, AbbVie Inc., North Chicago, IL 60064, United States. Electronic address: devalina.law@abbvie.com","institution_ids":["https://openalex.org/I2948539688"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5017289651","https://openalex.org/A5065235454"],"corresponding_institution_ids":["https://openalex.org/I2948539688"],"apc_list":{"value":3620,"currency":"USD","value_usd":3620},"apc_paid":null,"fwci":0.6552,"has_fulltext":false,"cited_by_count":4,"citation_normalized_percentile":{"value":0.60997555,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":97},"biblio":{"volume":"114","issue":"1","first_page":"383","last_page":"393"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.0015999999595806003,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.0010999999940395355,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/amorphous-nanoparticles","display_name":"amorphous nanoparticles","score":0.9340000152587891},{"id":"https://openalex.org/keywords/bcs-class-iv-drugs","display_name":"BCS class IV drugs","score":0.6980000138282776},{"id":"https://openalex.org/keywords/oral-drug-delivery","display_name":"oral drug delivery","score":0.5830000042915344},{"id":"https://openalex.org/keywords/scale-up","display_name":"scale-up","score":0.6110000014305115},{"id":"https://openalex.org/keywords/bioequivalence","display_name":"bioequivalence","score":0.6800000071525574},{"id":"https://openalex.org/keywords/freeze-drying","display_name":"freeze-drying","score":0.578000009059906},{"id":"https://openalex.org/keywords/particle-size","display_name":"particle size","score":0.5699999928474426},{"id":"https://openalex.org/keywords/formulation-stability","display_name":"formulation stability","score":0.5080000162124634},{"id":"https://openalex.org/keywords/oral-suspension","display_name":"oral suspension","score":0.5090000033378601},{"id":"https://openalex.org/keywords/amorphous-solid-dispersions","display_name":"amorphous solid dispersions","score":0.6330000162124634},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.546999990940094}],"concepts":[{"id":"https://openalex.org/C181389837","wikidata":"https://www.wikidata.org/wiki/Q461809","display_name":"Bioavailability","level":2,"score":0.8808795213699341},{"id":"https://openalex.org/C155672457","wikidata":"https://www.wikidata.org/wiki/Q61231","display_name":"Nanoparticle","level":2,"score":0.668719470500946},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.5538132786750793},{"id":"https://openalex.org/C56052488","wikidata":"https://www.wikidata.org/wiki/Q103382","display_name":"Amorphous solid","level":2,"score":0.5332977771759033},{"id":"https://openalex.org/C2779820397","wikidata":"https://www.wikidata.org/wiki/Q1392806","display_name":"Drug delivery","level":2,"score":0.5278744101524353},{"id":"https://openalex.org/C171250308","wikidata":"https://www.wikidata.org/wiki/Q11468","display_name":"Nanotechnology","level":1,"score":0.4684334695339203},{"id":"https://openalex.org/C45206210","wikidata":"https://www.wikidata.org/wiki/Q2415817","display_name":"Nanoscopic scale","level":2,"score":0.4298224449157715},{"id":"https://openalex.org/C192562407","wikidata":"https://www.wikidata.org/wiki/Q228736","display_name":"Materials science","level":0,"score":0.41203680634498596},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3862684369087219},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3460976481437683},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.1786603033542633},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.17616361379623413}],"mesh":[{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001682","descriptor_name":"Biological Availability","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D002626","descriptor_name":"Chemistry, Pharmaceutical","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D004339","descriptor_name":"Drug Compounding","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D004355","descriptor_name":"Drug Stability","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005612","descriptor_name":"Freeze Drying","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010316","descriptor_name":"Particle Size","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011208","descriptor_name":"Powders","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012995","descriptor_name":"Solubility","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013810","descriptor_name":"Therapeutic Equivalency","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D053758","descriptor_name":"Nanoparticles","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.xphs.2024.10.014","doi":"https://doi.org/10.1016/j.xphs.2024.10.014","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.xphs.2024.10.014","pdf_url":null,"source":{"id":"https://openalex.org/S130661733","display_name":"Journal of Pharmaceutical Sciences","issn_l":"0022-3549","issn":["0022-3549","1520-6017"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Pharmaceutical Sciences","raw_type":"journal-article"},{"id":"pmid:39427713","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/39427713","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of pharmaceutical sciences","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9074000120162964,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320309117","display_name":"AbbVie","ror":"https://ror.org/02g5p4n58"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":40,"referenced_works":["https://openalex.org/W1697337825","https://openalex.org/W1969018013","https://openalex.org/W1976021540","https://openalex.org/W1991106213","https://openalex.org/W2005460939","https://openalex.org/W2015203678","https://openalex.org/W2028019892","https://openalex.org/W2028883574","https://openalex.org/W2042537919","https://openalex.org/W2052888695","https://openalex.org/W2069580393","https://openalex.org/W2071215562","https://openalex.org/W2071988345","https://openalex.org/W2077781847","https://openalex.org/W2086892631","https://openalex.org/W2091368886","https://openalex.org/W2246665909","https://openalex.org/W2304404543","https://openalex.org/W2320607110","https://openalex.org/W2345916941","https://openalex.org/W2346169493","https://openalex.org/W2465228760","https://openalex.org/W2555239487","https://openalex.org/W2622240386","https://openalex.org/W2739283439","https://openalex.org/W2809031429","https://openalex.org/W2895658037","https://openalex.org/W2900438200","https://openalex.org/W2911693126","https://openalex.org/W2913392672","https://openalex.org/W2939818942","https://openalex.org/W2989431021","https://openalex.org/W3009735482","https://openalex.org/W3036803938","https://openalex.org/W4304889726","https://openalex.org/W4362703779","https://openalex.org/W4387538823","https://openalex.org/W4387931574","https://openalex.org/W4401836289","https://openalex.org/W6856747755"],"related_works":["https://openalex.org/W4387538823","https://openalex.org/W3022031993","https://openalex.org/W2964952642","https://openalex.org/W4304889726","https://openalex.org/W4387931574","https://openalex.org/W2939818942","https://openalex.org/W1970979810","https://openalex.org/W2749965621","https://openalex.org/W2198126155","https://openalex.org/W4413048225"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2024-10-19T00:00:00"}